RAD Biomed is part of the RAD Group, one of Israel’s most accomplished startup-to-successful-exit generators.
The RAD Group has been named "the most fertile ground" for creating Israeli entrepreneurs, having already produced 56 "serial entrepreneurs".
The RAD Group knows what practical steps are needed to guide a startup to commercial success,– through sales, IPOs (8 IPOs to date, with 4 companies currently listed on the NASDAQ), and exit (10 exits to date).
RAD BioMed’s co-founders, Mr. Yehuda Zisapel and Prof. Nava Zisapel, also co-founded Neurim Ltd., a leading Israeli biopharma company which developed Circadin®, a globally marketed treatment for sleep disorders.
Building on a track record of
entrepreneurial DNA and decades of company-building success, we are uniquely
positioned to identify breakthrough technologies and transform them into